Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
To meet the requirements for rapid tumor growth, a complex array of non-neoplastic cells are recruited to the tumor microenvironment. These cells facilitate tumor development by providing matrices, cytokines, growth factors, as well as vascular networks for nutrient and waste exchange, however their precise origins remain unclear. Through multicolored tissue transplant procedures; we have quantitatively determined the contribution of bone marrow-derived and adipose-derived cells to stromal populations within syngeneic ovarian and breast murine tumors. Our results indicate that subpopulations of tumor-associated fibroblasts (TAFs) are recruited from two distinct sources. The majority of fibroblast specific protein (FSP) positive and fibroblast activation protein (FAP) positive TAFs originate from mesenchymal stem/stromal cells (MSC) located in bone marrow sources, whereas most vascular and fibrovascular stroma (pericytes, α-SMA(+) myofibroblasts, and endothelial cells) originates from neighboring adipose tissue. These results highlight the capacity for tumors to utilize multiple sources of structural cells in a systematic and discriminative manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“MSC can be mobilized and recruited to active tumor sites, where they can incorporate into the tumor’s microenvironment [5, 68, 100–103].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725 · cited 1×
“The existence of a circulating bone marrow-derived endothelial progenitor (BM EPC) has been a topic of controversy for the past decade, dating back to its initial description by Asahara and colleagues in 1997 [39].”
BackgroundMultilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., Benhaim, P., Lorenz, H. P., & Hedrick, M. H. (2001) · Tissue Engineering · doi:10.1089/107632701300062859 · Cited by 7,956 · cited 1×
“Within the stromal fraction of WAT, progenitors with a similar phenotype, proliferative rate and differential capacity to BM MSC have been identified [47,54].”
BackgroundOverweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696 · cited 1×
“Obesity has been determined as a predisposing factor for cancer development and is associated with poor prognosis of certain cancer types [50].”
BackgroundKern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0342 · Cited by 3,370
Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., Kearne, M., Magner, M., & Isner, J. M. (1999) · Circulation Research · doi:10.1161/01.res.85.3.221 · Cited by 3,253 · cited 2×
“BM EPC have been reported to contribute significantly to tumor vasculature in many investigations [6,32,33].”
BackgroundAdipose-derived stem cells for regenerative medicine
Gimble, J. M., Katz, A. J., & Bunnell, B. A. (2007) · Circulation Research · doi:10.1161/01.res.0000265074.83288.09 · Cited by 2,332 · cited 1×
“Within the stromal fraction of WAT, progenitors with a similar phenotype, proliferative rate and differential capacity to BM MSC have been identified [47,54].”
BackgroundDistinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860 · cited 2×
“BM EPC have been reported to contribute significantly to tumor vasculature in many investigations [6,32,33].”
BackgroundDeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715
De Palma, M., Venneri, M. A., Galli, R., Sergi, L. S., Politi, L. S., Sampaolesi, M., & Naldini, L. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.002 · Cited by 1,311
Research works printed but not linked: 1
- Studeny M Marini FC Zompetta C Champlin RE Filder IJ 2001 Bone marrow derived mesenchymal stem cells serve as precursors for stromal fibroblasts in malignant tumors and show potential for cancer therapy. Blood 9 697a
Cited by
Items 201–300 of 370
Tumor microenvironment and the role of mesenchymal stromal cells
KUCEROVA, L., & SKOLEKOVA, S. (2012) · Neoplasma · doi:10.4149/neo_2013_001 · Cited by 27
Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer
Suzuki, J., Tsuboi, M., & Ishii, G. (2022) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2022.2019018 · Cited by 31
“surrounding the tumor tissues, including epithelial cells that undergo epithelial mesenchymal transition (EMT) [23], pericytes [26], stellate cells [27], and preadipocytes [28].”
BackgroundDrug Resistance: The Role of Exosomal miRNA in the Microenvironment of Hematopoietic Tumors
Cariello, M., Squilla, A., Piacente, M., Venutolo, G., & Fasano, A. (2022) · Molecules · doi:10.3390/molecules28010116 · Cited by 32
“The TME, therefore, consists of a diversified cellular and acellular environment in which cancer stem cells (CSC) can grow and develop, thanks to stromal and immune cells that are used by the tumor to create a self-sustaining surrounding environment [57].”
BackgroundBone marrow cells as precursors of the tumor stroma
Worthley, D. L., Si, Y., Quante, M., Churchill, M., Mukherjee, S., & Wang, T. C. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.03.006 · Cited by 29
“Whilst extramedullary organs lack the obvious osteoblasts and chondrocytes of the bone marrow, the intestinal myofibroblast sheath that rests just beneath the epithelial basement membrane is proposed to have an important role in intestinal stem cell function and throughout the mucosa perivascular stromal cells may als…”
Storti, G., Scioli, M. G., Kim, B., Terriaca, S., Fiorelli, E., Orlandi, A., & Cervelli, V. (2021) · Cells · doi:10.3390/cells10082117 · Cited by 26
“Adipose tissue can be roughly divided into white adipose tissue (WAT), brown adipose tissue (BAT), and a third type that has been recently identified and termed beige adipose tissue, which has features between WAT and BAT.”
BackgroundInfluentialHendijani, F. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2014.10.015 · Cited by 27
Ávila-Ibarra, L. R., Mora‐García, M. D. L., García‐Rocha, R., Hernández‐Montes, J., Weiss‐Steider, B., Montesinos, J. J., Soberon, M. L., García‐López, P., López, C. A. D., Torres‐Pineda, D. B., et al. (2019) · Stem Cells and Development · doi:10.1089/scd.2018.0183 · Cited by 28
Plavá, J., Cihova, M., Buríková, M., Boháč, M., Adamkov, M., Drahošová, S., Rusnáková, D., Pinďák, D., Karaba, M., Šimo, J., et al. (2020) · Cells · doi:10.3390/cells9020480 · Cited by 27
Guillaume, V. G. J., Ruhl, T., Boos, A. M., & Beier, J. P. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac002 · Cited by 28
Salvatore, V., Focaroli, S., Teti, G., Mazzotti, A., & Falconi, M. (2015) · Oncotarget · doi:10.18632/oncotarget.4902 · Cited by 29
“Tumor cells may alter the surrounding stroma through direct cell contact or by secreting paracrine-soluble factors, inducing cell modification and extracellular matrix (ECM) alterations [1].”
BackgroundThe Transcription Factor Hif-1 Enhances the Radio-Resistance of Mouse MSCs
Calvo‐Asensio, I., Dillon, E., Lowndes, N. F., & Ceredig, R. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00439 · Cited by 28
“…(Hanahan and Coussens, 2012; Kidd et al., 2012) where they are transformed into CAFs and promote tumorigenesis through various mechanisms (Kraman et al., 2010; Hanahan and Weinberg, 2011; Cuiffo and Karnoub, 2012; Hanahan and Coussens, 2012; Kidd et al., 2012; Barcellos-deSouza et al., 2013).”
BackgroundOta, D., Kanayama, M., Matsui, Y., Ito, K., Maeda, N., Kutomi, G., Hirata, K., Torigoe, T., Sato, N., Takaoka, A., et al. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1183-9 · Cited by 27
Zhou, J., Ma, X., Liu, X., Liu, Y., Fu, J., Qi, Y., & Liu, H. (2024) · Genes & Genomics · doi:10.1007/s13258-024-01554-2 · Cited by 27
“The TME comprises a variety of immune cells, cancer-associated fibroblasts, endothelial cells, pericytes, and various resident tissue cells (Kidd et al. 2012).”
SACCA, P. A., Mazza, O., Scorticati, C. H., Vitagliano, G. J., Casas, G., & Calvo, J. C. (2018) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20110 · Cited by 23
Szewc, M., Radzikowska-Büchner, E., Wdowiak, P., Kozak, J., Kuszta, P., Niezabitowska, E., Matysiak, J., Kubiński, K., & Masłyk, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052745 · Cited by 26
“It has been reported that MSCs recruited into the tumor microenvironment may have varied potential and origin due to different types of MSCs (from distinct tissues) expressing a distinct set of genes [17,55,56].”
BackgroundShao, H., Cai, L., Moller, M. G., Issac, B., Zhang, L., Owyong, M., Moscowitz, A. E., Vázquez-Padrón, R. I., Radtke, F., & Liu, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.13021 · Cited by 22
“CAF consist of a heterogeneous population of cells and can be derived from multiple origins, including infiltrated local tissue fibroblasts, recruited bone marrow–derived MSC (BMD-MSC), and perhaps transdifferentiated epithelial and endothelial cells [9–11].”
BackgroundCXCR4 or CXCR7 Antagonists Treat Endometriosis by Reducing Bone-Marrow Cell Trafficking
Pluchino, N., Mamillapalli, R., Shaikh, S., Habata, S., Tal, A., Gaye, M., & Taylor, H. S. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14933 · Cited by 28
Integrated Analysis of Clinical Outcome of Mesenchymal Stem Cell-related Genes in Pan-cancer
Jiang, M., Zhu, D., Zhao, D., Liu, Y., Li, J., & Zheng, Z. (2024) · Current Genomics · doi:10.2174/0113892029291247240422060811 · Cited by 24
Shearer, J. J., Wold, E. A., Umbaugh, C. S., Lichti, C. F., Nilsson, C. L., & Figueiredo, M. L. (2015) · Environmental Health Perspectives · doi:10.1289/ehp.1510090 · Cited by 26
“2014), emerging evidence has suggested that endogenous ASCs may also play a critical role in tumor progression depending on the cellular context (Barron and Rowley 2012; Kidd et al. 2012).”
BackgroundNie, X., Tang, J., Liu, Y., Cai, R., Miao, Q., Zhao, Y., & Chen, C. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.03.013 · Cited by 23
Guimarães, V. S. N., Vidal, M. T. A., Valverde, L. D. F., de Oliveira, M. G., da Rocha, L. D. O. S., Coelho, P. L. C., Soares, F. A., Souza, B. S. D. F., Bezerra, D. P., Coletta, R. D., et al. (2020) · Journal of Molecular Histology · doi:10.1007/s10735-020-09913-5 · Cited by 22
Ahmed, M. A. M., & Nagelkerke, A. (2021) · Organs-on-a-Chip · doi:10.1016/j.ooc.2021.100012 · Cited by 25
Barrera, L. N., Ridley, P., Bermejo‐Rodríguez, C., Costello, E., & Pérez-Mancera, P. A. (2022) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-022-00899-0 · Cited by 23
Enhanced Adhesion of Stromal Cells to Invasive Cancer Cells Regulated by Cadherin 11
McAndrews, K. M., Yi, J., McGrail, D. J., & Dawson, M. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00353 · Cited by 23
Huang, C., Tao, L., Wang, X., & Pang, Z. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27835 · Cited by 23
“Though cumulative results uncover that a complicated interaction exists between cancer cells and stromal cells and that stromal composition is known to be different between tumors (Kidd et al., 2012), little is known about mechanisms of communication between the stroma and tumor cells.”
BackgroundLi, M., Li, X., Zhao, L., Zhou, J., Cheng, Y., Xu, B., Wang, J., & Wei, L. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1568743 · Cited by 21
Bone marrow microenvironment in cancer patients: immunological aspects and clinical implications
Stefanovic, S., Schütz, F., Sohn, C., Beckhove, P., & Domschke, C. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9397-1 · Cited by 21
“[119] have demonstrated that the majority of intratumoral fibroblast-specific protein-positive and fibroblast activation protein-positive tumor-associated fibroblasts (TAFs) originate from BM MSCs.”
BackgroundRoshani, M., Baniebrahimi, G., Mousavi, M., Zare, N., Sadeghi, R., Salarinia, R., Sheida, A., Molavizadeh, D., Sadeghi, S., Moammer, F., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1014949 · Cited by 20
Shining the light on mesenchymal stem cell-derived exosomes in breast cancer
Al‐Awsi, G. R. L., Alsaikhan, F., Margiana, R., Ahmad, I., Patra, I., Najm, M. A. A., Yasin, G., Rasulova, I., Hammid, A. T., Kzar, H. H., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03245-3 · Cited by 24
Mitchell, M. I., & Loudig, O. D. (2023) · Biomedicines · doi:10.3390/biomedicines11092534 · Cited by 24
“…as inflammatory immune cells (i.e., macrophages, dendritic cells, neutrophils, and myeloid-derived suppressor cells), adipocytes, fibrob-lasts, and endothelial cells in addition to non-cancerous and cancerous epithelial cells, all contribute to what is termed the tumor microenvironment (TME) [2–4].”
Adipose tissue and breast cancer progression: A link between metabolism and cancer
Bertolini, F. (2013) · The Breast · doi:10.1016/j.breast.2013.07.009 · Cited by 23
“[6] have shown in syngenic models of ovarian and breast tumors that most vascular and fibrovascular stroma (including pericytes and endothelial cells) originates from neighboring WAT and not from marrow-derived cells.”
BackgroundTillmanns, J., Weiglein, J. M., Neuser, J., Fraccarollo, D., Galuppo, P., König, T., Diekmann, J., Roß, T. L., Bengel, F. M., Bauersachs, J. K., et al. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132044 · Cited by 19
Akrish, S. J., Rachmiel, A., Sabo, E., Vered, M., & Ben‐Izhak, O. (2016) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12503 · Cited by 19
“Myofibroblasts play important regulatory roles in normal biologic processes such as biological wound healing and embryogenesis (10).”
BackgroundTetrac as an anti-angiogenic agent in cancer
Schmohl, K. A., Nelson, P. J., & Spitzweg, C. (2019) · Endocrine-Related Cancer · doi:10.1530/erc-19-0058 · Cited by 18
Cen, S., Xu, H., Liu, Z., Zhao, R., Pan, H., & Han, W. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac007 · Cited by 17
Comparison of different sources of mesenchymal stem cells: focus on inflammatory bowel disease
Shi, L., Chen, L., Gao, X., Sun, X., Jin, G., Yang, Y., Shao, Y., Zhu, F., & Zhou, G. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01468-1 · Cited by 22
“Within the tumor microenvironment, these MSC contribute to crucial processes such as extracellular matrix remodeling, enhancing motility, and facilitating metastasis (Kidd et al. 2012).”
Antoon, R., Wang, X., Saleh, A. H., Warrington, J., Hedley, D. W., & Keating, A. (2022) · Cytotherapy · doi:10.1016/j.jcyt.2021.12.005 · Cited by 19
Mesenchymal Stromal Cell-Based Targeted Therapy Pancreatic Cancer: Progress and Challenges
Ma, Z., Hua, J., Liu, J., Zhang, B., Wang, W., Yu, X., & Xu, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043559 · Cited by 21
Role of Endothelial Cells and Fibroblasts in Multiple Myeloma Angiogenic Switch
Ribatti, D., & Vacca, A. (2016) · Cancer treatment and research · doi:10.1007/978-3-319-40320-5_5 · Cited by 19
Establishment and Characterization of a Brca1−/−, p53−/− Mouse Mammary Tumor Cell Line
Hámori, L., Kudlik, G., Szebényi, K., Kucsma, N., Szeder, B., Póti, Á., Uher, F., Várady, G., Szüts, D., Tóvári, J., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041185 · Cited by 21
“[92] showed that while fibroblast/mesenchymal stem cells originate from the bone marrow, vascular and fibrovascular support is derived from the local fat tissue.”
BackgroundGil-Chinchilla, J. I., Zapata, A. G., Moraleda, J. M., & García‐Bernal, D. (2024) · Biomolecules · doi:10.3390/biom14070734 · Cited by 21
“Once MSCs reach the tumour, they contribute to its stroma by differentiating into fibrovascular cells such as endothelial cells, pericytes and possibly tumour-associated fibroblasts involved in the extracellular matrix remodelling [38].”
BackgroundObesity, proinflammatory mediators, adipose tissue progenitors, and breast cancer
Bertolini, F., Orecchioni, S., Petit, J., & Kolonin, M. G. (2014) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000130 · Cited by 17
Blomberg, R., Beiting, D. P., Wabitsch, M., & Puré, E. (2019) · Matrix Biology · doi:10.1016/j.matbio.2019.07.007 · Cited by 16
Yan, H., Shi, J., Dai, Y., Li, X., Wu, Y., Zhang, J., Gu, Z., Zhang, C., & Leng, J. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02580-4 · Cited by 24
“Stromal cells TME is composed of tumor cells and nearby endogenous stromal cells [57, 58].”
BackgroundRahrotaban, S., Mahdavi, N., Abdollahi, A., Yazdani, F., Kaghazloo, A., & Derakhshan, S. (2018) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000687 · Cited by 14
Ilie, D. S., Mitroi, G. G., Păun, I., Ţenea-Cojan, T.-Ş., Neamţu, C., Totolici, B. D., Sapalidis, K. G., Mogoantă, S. Ş., & Murea, A. (2021) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.62.1.11 · Cited by 19
“Tumor microenvironment is a complex morphological and molecular structure, which reflects the interaction between the tumor cells and the adjacent stromal cells, especially the interaction with fibroblasts and also inflammatory cells [25].”
BackgroundMesenchymal Stromal Cells from Female Donors Enhance Breast Cancer Cell Proliferation in vitro
Pasanen, I., Pietilä, M., Lehtonen, S. T., Lehtilahti, E., Hakkarainen, T., Sequeiros, R. T. B., Lehenkari, P. P., & Kuvaja, P. (2014) · Oncology · doi:10.1159/000368556 · Cited by 15
Targeted antitumor therapy mediated by prodrug-activating mesenchymal stromal cells
Kučerová, L., Durinikova, E., Toro, L., Cihova, M., Miklikova, S., Poturnajova, M., Kozovská, Z., & Matúšková, M. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.08.016 · Cited by 13
Kitaeva, K. V., Prudnikov, T. S., Gomzikova, M. O., Kletukhina, S. K., James, V. H., Rizvanov, A. A., & Solovyeva, V. V. (2019) · BioNanoScience · doi:10.1007/s12668-019-00625-z · Cited by 13
Cytokine signaling regulating adipose stromal cell trafficking
Zhang, Y., & Kolonin, M. G. (2016) · Adipocyte · doi:10.1080/21623945.2016.1220452 · Cited by 15
The Role of Metabolic Changes in Shaping the Fate of Cancer-Associated Adipose Stem Cells
Cantini, G., Franco, A. D., Mannelli, M., Scimè, A., Maggi, M., & Luconi, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00332 · Cited by 13
Zinc-alpha-2-glycoprotein Secreted by Triple-Negative Breast Cancer Promotes Peritumoral Fibrosis
Verma, S., Giagnocavo, S. D., Curtin, M. C., Arumugam, M., Osburn-Staker, S. M., Wang, G., Atkinson, A. E., Nix, D. A., Lum, D. H., Cox, J. E., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0218 · Cited by 14
Luo, Q., Liu, P., Yu, P., & Qin, T. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10508-2 · Cited by 13
Parathyroid Tumor Microenvironment
Verdelli, C., Vaira, V., & Corbetta, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-36214-0_3 · Cited by 13
FGFR‑related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review)
Sołek, J. M., Braun, M., Sądej, R., & Romańska, H. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5682 · Cited by 16
Multipotent Mesenchymal Stromal Cells: Possible Culprits in Solid Tumors?
Johann, P. D., & Müller, I. (2015) · Stem Cells International · doi:10.1155/2015/914632 · Cited by 13
“The exact proportion ofmesenchymal cells in tumors that originate from the bone marrow may vary: In a study of ovarian cancer as much as 60–70% of the stroma could be traced back to BM-MSCs [31].”
BackgroundWang, X., & Huang, C. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04719-5 · Cited by 13
Cancer-associated fibroblasts in breast cancer in the single-cell era: Opportunities and challenges
Yang, J., Xin, B., Wang, X., & Wan, Y. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189291 · Cited by 18
Li, M., Li, X., Zhao, L., Zhou, J., Cheng, Y., Wang, J., & Wei, L. (2018) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13820 · Cited by 13
Kou, Z., Liu, C., Zhang, W., Sun, C., Liu, L., & Zhang, Q. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5642 · Cited by 13
Allam, O., Samarani, S., & Ahmad, A. (2013) · AIDS · doi:10.1097/qad.0b013e32836010f7 · Cited by 11
“There is also evidence suggesting differentiation of MSCs into immunosuppressive tumorassociated fibroblasts [23].”
BackgroundPaiboon, N., Kamprom, W., Manochantr, S., Tantrawatpan, C., Tantikanlayaporn, D., Roytrakul, S., & Kheolamai, P. (2019) · Stem Cells International · doi:10.1155/2019/9748795 · Cited by 10
[Treatment with ramelteon for sleep disturbance in severely disabled children and young adults].
Miyamoto, A., Fukuda, I., Tanaka, H., Oka, R., Araki, A., & Cho, K. (2013) · PubMed · Cited by 16
Deng, H., Chen, Y., Wang, J., & An, R. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274897 · Cited by 12
“The tumor microenvironment (TME) is a heterogeneous population of cells comprised of diverse immune cells, tumor cells and stromal cells [14, 15].”
BackgroundCopper-induced liver fibrosis affects the behavior of bone marrow cells in primary culture
Божков, А. И., Ivanov, E. G., Kuznetsova, Y. A., Ohiienko, S. L., & Bondar’, A. Y. (2017) · Frontiers in Biology · doi:10.1007/s11515-017-1458-y · Cited by 10
“, 2013), leading to the development of different pathologies (Kidd et al., 2012; Nwajei and Konopleva, 2013; Schepers et al., 2013).”
Background3D multicellular models reflect the efficiency of MSC-directed enzyme/prodrug treatment
Bohovic, R., Demková, L., Cihova, M., Skolekova, S., Durinikova, E., Toro, L., Tyčiaková, S., Kozovská, Z., Matúšková, M., & Kučerová, L. (2015) · Neoplasma · doi:10.4149/neo_2015_063 · Cited by 8
“Based on our data, the best outcomes with the CD-MSC/5FC regimen might be expected in the tumors which incorporate substantial part of the tumor stroma from the adipose tissuederived precursors (such as ovarian cancer and breast cancer models) – ideally close to 20% [26; 27].”
BackgroundMethodZhang, T., Lee, W., Rui, Y., Cheng, T. Y., & Li, G. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt047.9 · Cited by 8
“Various different mobilized cell types including normal fibroblasts, preadipocytes, epithelial cells and smooth muscle cells have been shown to be the sources of CAFs [11].”
Muller, C., Nieto, L., & Valet, P. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7660-3_7 · Cited by 9
Saha, A., Hamilton‐Reeves, J. M., & DiGiovanni, J. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10056-0 · Cited by 8
Cao, D., Naiyila, X., Li, J., Huang, Y. C., Chen, Z., Chen, B., Li, J., Guo, J., Dong, Q., Ai, J., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.705280 · Cited by 9
“CAFs can also be derived from bone marrow mesenchymal stem cells (Figure 1), transforming from resident epithelium or endothelial cells in the tumor stroma via EMT or endothelial–mesenchymal transition (EndMT), respectively (Kidd et al., 2012).”
BackgroundSoh, S., Han, S., Ka, H. I., Mun, S. H., Kim, W., Oh, G., & Yang, Y. D. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01143-y · Cited by 8
“Recent evidence shows that BMSCs can migrate into specific types of tumors in which they become resident MSCs [18–21].”
BackgroundSwietlicki, E. A., Bala, S., Lu, J., Shaker, A., Kularatna, G., Levin, M. S., & Rubin, D. C. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00486.2012 · Cited by 7
Mesenchymal Stem Cell Transition to Tumor-Associated Stromal Cells Contributes to Cancer Progression
Bussard, K. M., Spaeth, E. L., Mutkus, L. A., Stumpf, K., & Marini, F. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803102-5.00011-2 · Cited by 10
Self-citationHsu, C., Saleh, R. O., Mohammed, J. S., Mansuri, N., Rekha, M. M., Kundlas, M., Anand, A., Sahoo, S., Zwamel, A. H., & Hulail, H. M. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04565-2 · Cited by 7
“…et al. 2015), several additional potential sources include bone marrow-derived mesenchymal stem cells (Quante et al. 2011), adipocyte precursors (Kidd et al. 2012), endothelial cells via endothelial-to-mesenchymal transition (Zeis-berg et al. 2007), mesothelial cells (Sandoval et al. 2013), and…”
Role of cancer-associated fibroblasts in tumor microenvironment
Mir, M. A., Sofi, S., & Aisha, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-443-18696-7.00002-6 · Cited by 6
Decoding secret role of mesenchymal stem cells in regulating cancer stem cells and drug resistance
Panda, S. K., Robinson, N., & Desiderio, V. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189205 · Cited by 7
Spaeth, E. L., Booth, C. M., & Marini, F. C. (2013) · Journal of Visualized Experiments · doi:10.3791/50385 · Cited by 8
Self-citationMarín‐Aquino, L. A., Mora‐García, M. D. L., Moreno-Lafont, M. C., García‐Rocha, R., Montesinos, J. J., López‐Santiago, R., Sánchez‐Torres, L. E., Torres‐Pineda, D. B., Weiss‐Steider, B., Hernández‐Montes, J., et al. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4010 · Cited by 9
Mesenchymal Stem Cells: How Can we Realize their Therapeutic Potential in Cancer Therapy?
Baird, S. K. (2015) · Journal of Clinical & Experimental Pathology · doi:10.4172/2161-0681.1000206 · Cited by 10
“The movement of the fluorescent cells can be followed and cells can even be isolated from the tumour for further in vitro study [3].”
BackgroundResultInfluentialAssessment of the Cancer Risk of the Fat-Grafted Breast in a Murine Model
Claro, F., Moreira, L. R., Morari, J., Sarian, L. O., Pinto, G. A., Velloso, L. A., & Pinto-Neto, A. M. (2016) · Aesthetic Surgery Journal · doi:10.1093/asj/sjw209 · Cited by 10
A brief glimpse of a tangled web in a small world: Tumor microenvironment
Talaat, I. M., & Kim, B. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1002715 · Cited by 6
Dipeptidyl Peptidase-IV and Related Proteases in Brain Tumors
Bušek, P., & Šedo, A. (2013) · InTech eBooks · doi:10.5772/53888 · Cited by 6
“FAP may be also expressed by peri‐ cytes [138], although in some cancer models its expression was restricted to isolated infiltrating stromal cells rather than pericytes [147].”
Thomas, A., Pathak, N., Moses, L., & Munirathinam, G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-13212-4.00002-7 · Cited by 5
Fang, Y., Tan, C., Zheng, Z., Yang, J., Tang, J., Guo, R., Silli, E. K., Chen, Z., Chen, J., Ge, R., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116849 · Cited by 6
Chang, J., Lo, Z. H. Y., Alenizi, S., & Kovačević, Ž. (2023) · Cancers · doi:10.3390/cancers15102779 · Cited by 7
“CAFs are derived from resident fibroblasts [88], bone marrow-derived mesenchymal stem cells (BMD-MSCs) [89], adipocytes [90], aPSCs [91], and epithelial cells that have undergone EMT [92].”
BackgroundJia, Z., Long, D., & Yu, Y. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44100306 · Cited by 4
Wu, X., Ma, Z., Yang, Y., Mu, Y., & Wu, D. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03604-0 · Cited by 5
“This finding conflicts with our results and may be the consequence of different cell sources [43], different culture conditions, or different tumors [44, 45].”
ResultNahas, G. R., Walker, N. D., Bryan, M., & Rameshwar, P. (2015) · Breast Cancer Basic and Clinical Research · doi:10.4137/bcbcr.s29425 · Cited by 5
Does Choice of Reconstruction Type Affect Survival in Patients With Metastatic Breast Cancer?
Qi, X., Wang, K., Sun, D., & Zhang, L. (2019) · Journal of Surgical Research · doi:10.1016/j.jss.2019.09.057 · Cited by 4
Xu, L., Fang, Q., Miao, Y., Xu, M., Wang, Y., Sun, L., & Jia, X. (2021) · Bioengineered · doi:10.1080/21655979.2021.1947631 · Cited by 4
Zhou, Y., Zhu, J., Gu, M., & Gu, K. (2023) · Journal of Oncology · doi:10.1155/2023/6851036 · Cited by 4
Cancer-associated fibroblasts serve as decoys to suppress NK cell anti-cancer cytotoxicityPreprint
Ben‐Shmuel, A., Gruper, Y., Levi-Galibov, O., Rosenberg-Fogler, H., Carradori, G., Stein, Y., Dadiani, M., Naumova, M., Nevo, R., Morzaev‐Sulzbach, D., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.23.568355 · Cited by 4
The Role of Recruited Adipose Stromal Cells and Their Fibroblastic Differentiation in Cancer
Cai, L., Kolonin, M. G., & Anastassiou, D. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl36559 · Cited by 3
Mesenchymal Stem Cells as Gene Delivery Vehicles
Porada, C. D., & Almeida-Por, G. (2013) · InTech eBooks · doi:10.5772/53240 · Cited by 4
“Indeed, unraveling the role played by MSC with‐ in the tumor microenvironment is currently an area of active research [191, 192, 262-265, 267-269].”
BackgroundWang, Y. Y., Ren, G., Petit, J., & Muller, C. (2013) · Journal of Craniofacial Surgery · doi:10.1097/scs.0b013e31828b6c84 · Cited by 6
“These studies using fluorescent-tagged cells show that these ADSCs contribute to the formation of most vascular and fibrovascular stroma (pericytes, >-smooth muscle actinYpositive myofibroblasts, and endothelial cells) in murine tumors.(18) Finally, the role of AT in tumor vascularization is also sustained by the pres…”
BackgroundLin, S., & Fu, S. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2012.12.016 · Cited by 3
“The study [8] with multicolored tissue transplant procedures also suggested that of the stromal cells, about 42% were bone marrow-derived and 58% were non-bone marrow-derived.”
BackgroundInfluentialUmbilical Cord Matrix Stem Cells for Cytotherapy of Breast Cancer
Ohta, N., Kawabata, A., Uppalapati, D., Ishiguro, S., Troyer, D. L., & Tamura, M. (2013) · Wiley eBooks · doi:10.1002/9781118660423.ch9 · Cited by 3
Sugrue, T., Calvo‐Asensio, I., & Ceredig, R. (2016) · Wiley eBooks · doi:10.1002/9781118907474.ch27 · Cited by 5
Sun, X., Wu, C., Lin, Y., Zhang, S., Zhao, X., & Wang, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34630 · Cited by 3
Cancer-Associated Fibroblasts: Heterogeneity and Bimodality in Oncogenesis
Lunina, N. A., Safina, D. R., & Kostrov, S. V. (2023) · Molecular Biology · doi:10.31857/s0026898423050105 · Cited by 2
Metadata
- Authors
- Kidd, S., Spaeth, E., Watson, K., Burks, J., Lu, H., Klopp, A., Andreeff, M., & Marini, F. C.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Marini, Frank C.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-02-20
- Volume
- 7
- Issue
- 2
- Pages
- e30563
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3282707
- OpenAlex
- W1972938311
- Cited by
- 371
- References
- 58
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 19 · 2023: 32 · 2022: 24 · 2021: 30 · 2020: 23 · 2019: 29 · 2018: 22 · 2017: 21 · 2016: 30 · 2015: 32 · 2014: 34 · 2013: 44 · 2012: 18
- FWCI
- 20.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- U.S. Department of Defense
- Ovarian Cancer Research Fund
- Susan G. Komen (BC083397)
- National Cancer Institute (P50CA116199, CA-16672, CA-55164, R01CA109451, P01CA049639, R01NS06994, P01CA055164, Ca-116199, RC1CA146381, BC083397, CA109451, P50CA083639, P30CA016672, CA 49639)
- National Institute of Neurological Disorders and Stroke (R01NS069964, R01NS06994)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- tumor microenvironment, cancer-associated fibroblasts, mesenchymal stem cells, pericytes, myofibroblasts, endothelial cells, fibroblast activation protein, ovarian neoplasms, breast tumors, tissue transplantation
- MeSH terms
- Adipose Tissue, Animals, Bone Marrow Cells, Female, Mice, Inbred C57BL, Models, Biological, Biomarkers, Cell Line, Tumor, Green Fluorescent Proteins, Mice, Tumor Microenvironment, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.